Back

Long term adherence to prescribed cardiovascular medications in patients after percutaneous coronary intervention

30 August 2026 (10:06 - 10:18)
Organised by: Logo
Congress Presentation Part of: Optimising cardiovascular care delivery: acute complications, treatment pathways, and sustained patient adherence Chronic Nursing Care ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Trond Roed Pettersen

Haukeland University Hospital, Bergen (Norway)

4 More presentations in this session

Presentation thumbnail
A nurse-delivered analgesia pathway for severe pain reduction during radial access
Miss J. Gomez Carrillo (Murcia, ES)
Abstract Slides Video
Presentation thumbnail
More than one in four patients hospitalised for coronary artery disease report high medication concerns: findings from a multicentre observational cohort study
Ms D. Schaminee (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Home-based cardiac rehabilitation for people living with heart failure the DK: REACH-HF pilot study
Mrs M. Hansen (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
12-month outcomes following multidisciplinary management of postural orthostatic tachycardia syndrome (POTS)
Ms G. Wilson (Adelaide, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising cardiovascular care delivery: acute complications, treatment pathways, and sustained patient adherence
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 10:06 CET
You may be interested in
thumbnail
Congress Presentation
Trajectories of adherence to secondary prevention pharmacotherapy after coronary angiography: a retrospective population-based study
1 September 2025
thumbnail
Congress Presentation
Thrombocheck: a drug-drug interactions guide for cardiologists prescribing antithrombotic therapy
31 August 2025
thumbnail
Congress Presentation
How to monitor and support adherence to antihypertensive treatment?
29 August 2026
thumbnail
Congress Presentation
Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources